RWM
TXG icon

Raffa Wealth Management’s 10x Genomics TXG Stock Holding History

Raffa Wealth Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-31
Closed -$5.21K – 1124
2021
Q1 		$5.21K Hold
31
– – ﹤0.01% 396
2020
Q4 		$4.39K Sell
31
-14
-31% -$2.03K ﹤0.01% 390
2020
Q3 		$5.61K Sell
45
-11
-20% -$1.16K ﹤0.01% 310
2020
Q2 		$5K Buy
56
+24
+75% +$1.87K ﹤0.01% 317
2020
Q1 		$1.99K Buy
+32
New +$2.5K ﹤0.01% 430

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
MCAV
Meritech Capital Associates V Palo Alto, California $141M AUM 15.44% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Raffa Wealth Management's TXG Position: Q2 2021 in Review

Raffa Wealth Management sold out of 10x Genomics (TXG) in Q2 2021, closing a stake of 31 shares — an estimated $5.21K sold.

Raffa Wealth Management first reported a position in TXG in Q1 2020 and held it in 5 quarters. The position peaked at $5.61K in Q3 2020. 340 funds tracked by Wall St. Rank hold TXG as of Q2 2021.

  • Raffa Wealth Management reported no remaining 10x Genomics position as of Q2 2021 after selling out during the quarter.
  • Raffa Wealth Management sold 31 10x Genomics shares in Q2 2021, an estimated $5.21K.
  • Raffa Wealth Management first reported a position in 10x Genomics in Q1 2020 and held it in 5 quarters.
  • Raffa Wealth Management's 10x Genomics position peaked at $5.61K in Q3 2020.
  • 340 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2021.

Based on Raffa Wealth Management's 13F filing for Q2 2021, filed 27 Jul 2026.